fingolimod
CHEBI:CHEBI_63115
Definition
An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate.
Chemical Information
- Molecular Formula
- C19H33NO2
- Molecular Mass
- 307.47080
- Charge
- 0
- SMILES
- CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
- InChI
- InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3
- InChIKey
- KKGQTZUTZRNORY-UHFFFAOYSA-N
Alternative Names
- 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
- fingolimod
- fingolimodum
- FTY-720
- FTY720
Drug Classification
-
primary amino compoundView Class →
CHEBI:50994
-
aminodiolView Class →
CHEBI:22501
-
t261932
-
t261986
-
t262070
-
t262399
-
t262542
-
t262579
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:63115
- DRON_00010000
- 1012892
- oboInOwl#hasDbXref
- Wikipedia:Fingolimod
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- route
- ORAL
- package_ndc
- 65015-834-61
- package_description
- 100 kg in 1 DRUM (65015-834-61)
- spl_id
- 13a21056-33f7-a068-e063-6294a90a0208
- core#notation
- CHEBI:63115
- active_ingredient_strength
- 5 kg/5kg
- active_ingredient_name
- FINGOLIMOD LAURYL SULFATE
- unii
- J3HZQ9BE2S
- spl_set_id
- 5434bd4a-2610-0e17-4f14-513ff1cbb822
- upc
- 0372865257302
- pharm_class_moa
- Sphingosine 1-Phosphate Receptor Modulators [MoA]
- pharm_class
- Sphingosine 1-phosphate Receptor Modulator [EPC]
- pharm_class_epc
- Sphingosine 1-phosphate Receptor Modulator [EPC]
- nui
- N0000181815
- rxcui
- 2045493
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- dosage_form
- TABLET, ORALLY DISINTEGRATING
- labeler_name
- Cycle Pharmaceuticals Ltd
- marketing_start_date
- 20100921
- application_number
- ANDA207933
- product_ndc
- 0378-4525
- manufacturer_name
- Cycle Pharmaceuticals Ltd
- package_marketing_start_date
- 21-SEP-10
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1012892
- oboInOwl#hasDbXref
- Wikipedia:Fingolimod
- oboInOwl#id
- CHEBI:63115
- generic_name
- Fingolimod hydrochloride
- brand_name
- TASCENSO ODT
- brand_name_base
- TASCENSO ODT
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_73416
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_63113
- has_treatment
- http://purl.obolibrary.org/obo/DOID_2377
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30286
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_63113
- owl#annotatedSource
- t262916
- owl#someValuesFrom
- t3933241